This Viewpoint discusses the recent FDA-proposed draft guidance on benefit-risk assessment to guide its review of new drug and biological products and how this approach will enhance its mission to protect public health.
Source: JAMA Online First
| Curriculum Vitae | Résumé |
This Viewpoint discusses the recent FDA-proposed draft guidance on benefit-risk assessment to guide its review of new drug and biological products and how this approach will enhance its mission to protect public health.
Source: JAMA Online First